Autoimmune gastritis in autoimmune thyroid disease

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 7, 2015, Pages 686-693

  Venerito, M ^a   Radunz M ^a   Reschke, K ^a   Reinhold, D ^a   Frauenschlager K ^a   Jechorek, D ^a   Di Mario, F ^b   Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN; BIOLOGICAL MARKER; PEPSINOGEN II;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE GASTRITIS; AUTOIMMUNE THYROIDITIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRITIS; GOITER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; OXYNTIC GASTRIC ATROPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH ATROPHY; STOMACH PARIETAL CELL; STRUCTURED QUESTIONNAIRE; AGED; AUTOIMMUNE DISEASES; BIOPSY; BLOOD; GASTRITIS, ATROPHIC; IMMUNOLOGY; MIDDLE AGED; THYROID DISEASES;

ADULT; AGED; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GASTRITIS, ATROPHIC; GOITER; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PARIETAL CELLS, GASTRIC; PEPSINOGEN A; PEPSINOGEN C; SEROEPIDEMIOLOGIC STUDIES; THYROID DISEASES;

EID: 84926205641     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13097     Document Type: Article

References (34)

1. Checchi S, Montanaro A, Ciuoli C, et al,. Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis. Thyroid 2010; 20: 1385-9.
2. Wolf EM, Plieschnegger W, Geppert M, et al,. Changing prevalence patterns in endoscopic and histological diagnosis of gastritis? Data from a cross-sectional Central European multicentre study. Dig Liver Dis 2014; 46: 412-8.
3. Toh BH,. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev 2014; 13: 459-62.
4. Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK,. Aliment Pharmacol Ther 2014; 39: 1071-84.
5. Rugge M, de Boni M, Pennelli G, et al,. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010; 31: 1104-11.
6. Vannella L, Lahner E, Osborn J, et al,. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010; 31: 1042-50.
7. Venerito M, Malfertheiner P,. Dig Dis 2015; 33: 5-10.
8. Kuipers EJ, Uyterlinde AM, Peña AS, et al,. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-8.
9. Kuipers EJ,. Review article: relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1998; 12: 125-36.
10. Karnes WE Jr, Samloff IM, Siurala M, et al,. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167-74.
11. Ma JY, Borch K, Sjöstrand SE, Janzon L, Mardh S,. Positive correlation between H,K-Adenosine Triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 1994; 29: 961-5.
12. Negrini R, Savio A, Poiesi C, et al,. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655-65.
13. Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP,. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol 2014; 20: 613-29.
14. De Block CE, De Leeuw IH, Bogers JJ, et al,. Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus. Aliment Pharmacol Ther 2002; 16: 281-9.
15. Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H,. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev 2013; 22: 821-6.
16. Samloff IM, Taggart RT,. Pepsinogens, pepsins, and peptic ulcer. Clin Invest Med 1987; 10: 215-21.
17. Borch K, Axelsson CK, Halgreen H, et al,. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989; 24: 870-6.
18. Kekki M, Samloff IM, Varis K, Ihamäki T,. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991; 186: 109-16.
19. McNicholl AG, Forné M, Barrio J, et al,. Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2014; 26: 941-8.
20. Burman P, Karlsson FA, Lööf L, Axelsson CK, Szesci PB, Borch K,. H+,K-ATPase antibodies in autoimmune gastritis: observations on the development of pernicious anemia. Scand J Gastroenterol 1991; 26: 207-14.
21. Kahaly GJ, Dietlein M,. Cost estimation of thyroid disorders in Germany. Thyroid 2002; 12: 909-14.
22. Islami F, Sheikhattari P, Ren JS, Kamangar F,. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma-a systematic review and meta-analysis. Ann Oncol 2011; 22: 754-60.
23. Dixon M, Genta RM, Yardley JH, et al,. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
24. Rugge M, Correa P, Di Mario F, et al,. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008; 40: 650-8.
25. Wex T, Venerito M, Kreutzer J, Götze T, Kandulski A, Malfertheiner P,. Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010. Clin Vaccine Immunol 2011; 18: 2109-12.
26. Miki K,. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-"ABC method". Proc Jpn Acad Ser B Phys Biol Sci 2011; 87: 405-14.
27. Cho SJ, Choi IJ, Kook MC, et al,. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther 2013; 38: 1292-302.
28. Dinis-Ribeiro M, Areia M, de Vries AC, et al,.; European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94.
29. Rugge M, Fassan M, Pizzi M, Graham DY,. Letter: gastric cancer and pernicious anaemia-often Helicobacter pylori in disguise. Aliment Pharmacol Ther 2013; 37: 764-5.
30. Genta RM, Sonnenberg A,. Helicobacter-negative gastritis: a distinct entity unrelated to Helicobacter pylori infection. Aliment Pharmacol Ther 2015; 41: 218-26.
31. Vannella L, Lahner E, Osborn J, Annibale B,. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013; 37: 375-82.
32. Rugge M, Fassan M, Pizzi M, et al,. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012; 35: 1460-6.
33. Centanni M, Marignani M, Gargano L, et al,. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 1999; 159: 1726-30.
34. Joo YE, Park HK, Myung DS, et al,. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liv 2013; 7: 303-10.